Last reviewed · How we verify

Genotype Guided PPI Dosing — Competitive Intelligence Brief

Genotype Guided PPI Dosing (Genotype Guided PPI Dosing) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Proton pump inhibitor (PPI) — dosing optimization strategy. Area: Gastroenterology.

marketed Proton pump inhibitor (PPI) — dosing optimization strategy CYP2C19 (cytochrome P450 2C19 enzyme variants) Gastroenterology Small molecule Live · refreshed every 30 min

Target snapshot

Genotype Guided PPI Dosing (Genotype Guided PPI Dosing) — Nemours Children's Clinic. Genotype-guided PPI dosing optimizes proton pump inhibitor therapy by tailoring doses based on individual CYP2C19 metabolizer status to improve efficacy and safety.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Genotype Guided PPI Dosing TARGET Genotype Guided PPI Dosing Nemours Children's Clinic marketed Proton pump inhibitor (PPI) — dosing optimization strategy CYP2C19 (cytochrome P450 2C19 enzyme variants)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Proton pump inhibitor (PPI) — dosing optimization strategy class)

  1. Nemours Children's Clinic · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Genotype Guided PPI Dosing — Competitive Intelligence Brief. https://druglandscape.com/ci/genotype-guided-ppi-dosing. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: